Puerarin rescues intestinal barrier dysfunction and ameliorates colitis via NRF2-associated inhibition of ferroptosis
Frontiers in Medicine · 16.11.2026 · 13
DOI: 10.3389/fmed.2026.1996156 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Medicine, online erschienen am 16.11.2026. Verfasst von Hao Fang und 7 weiteren Autor:innen. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
The study aimed to clarify the link between ferroptosis and intestinal barrier dysfunction, investigate the underlying mechanisms of puerarin in colitis, and clarify the involvement of NRF2 signaling and gut microbiota modulation in its protective effects. Materials and methods Colitis was induced by dextran sulfate sodium (DSS) to evaluate the protective effects of puerarin. We combined RNA-seq with an analysis of public Gene Expression Omnibus (GEO) datasets to identify potential ferroptosis-related therapeutic targets in ulcerative colitis. Ferroptosis-related markers were assessed. Pharmacological interventions and small interfering RNA (siRNA)-mediated gene silencing were combined to investigate the potential mechanisms underlying the protective effects of puerarin against ferroptosis and on intestinal barrier integrity. Finally, 16S rRNA sequencing was conducted to characterize the gut microbiota and explore its potential association with puerarin treatment.
Results
Puerarin significantly ameliorated colitis, as evidenced by a reduced disease activity index, increased colon length, and reduced histological injury. RNA-seq suggested that ferroptosis was a potential mechanism underlying the protective effects of puerarin. Subsequent experiments indicated that DSS- or LPS-induced injury activated ferroptosis. Moreover, erastin-induced ferroptosis impaired intestinal barrier integrity, and ferrostatin-1 (Fer-1) reversed this impairment, supporting a contribution of ferroptosis to intestinal barrier disruption. Puerarin improved intestinal barrier integrity, at least partly by suppressing ferroptosis, and this effect was accompanied by increased NFE2L2 mRNA and NRF2 protein levels. Both ML385 treatment and NFE2L2 knockdown largely abolished the protective effects of puerarin, supporting the conclusion that these effects are at least partly mediated through NRF2 signaling. 16S rRNA sequencing revealed that puerarin partially modulated gut microbiota composition in DSS-induced colitis mice.
Conclusion
Puerarin ameliorates experimental colitis by protecting intestinal barrier function, at least partly through NRF2-associated inhibition of ferroptosis.
Zitieren
APA
Fang, H., Zhou, Z., Sun, S., Wu, S., Lou, Y., Wang, C., Chen, Z., & Xu, D. (2026). Puerarin rescues intestinal barrier dysfunction and ameliorates colitis via NRF2-associated inhibition of ferroptosis. Frontiers in Medicine, 13. https://doi.org/10.3389/fmed.2026.1996156
Vancouver
Fang H, Zhou Z, Sun S, Wu S, Lou Y, Wang C, et al. Puerarin rescues intestinal barrier dysfunction and ameliorates colitis via NRF2-associated inhibition of ferroptosis. Frontiers in Medicine. 2026;13. doi:10.3389/fmed.2026.1996156
BibTeX
@article{Fang2026,
author = {Fang, Hao and Zhou, Zhanyi and Sun, Shaopeng and Wu, Shuwen and Lou, Yijie and Wang, Chuyu and Chen, Zhe and Xu, Daogu},
title = {Puerarin rescues intestinal barrier dysfunction and ameliorates colitis via NRF2-associated inhibition of ferroptosis},
journal = {Frontiers in Medicine},
year = {2026},
volume = {13},
doi = {10.3389/fmed.2026.1996156}
}
EUVIMED